Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Temperature Imaging Application Illuminates Pathogenesis of Cancer and Other Diseases

By BiotechDaily International staff writers
Posted on 11 Feb 2013
Print article
Japanese researchers are investigating the functions of messenger ribonucleic acid (mRNA) has found a way to take a close look at the temperature distribution inside living cells. This new approach may lead to a better determination of diseases, such as cancer, which generates considerable intracellular heat.

This advance is the first time that the actual temperature distribution has been shown inside living cells. The investigators presented their findings at the 57th annual meeting of the Biophysical Society (BPS), held February 2-6, 2013, in Philadelphia (PA, USA).

Traditional temperature imaging techniques are deficient in spatial resolution and sensitivity, meaning these approaches are not capable of imaging very tiny temperature differences inside living cells. To resolve these problems, the scientists developed a new imaging application that combines a highly sensitive thermometer with an incredibly accurate detection technique, enabling the creation of detailed intracellular temperature maps.

“Our imaging method allows us to clearly see the temperature inside living cells, and we found that the temperature differs greatly depending on the location in the cell,” said Dr. Kohki Okabe, an assistant professor at the University of Tokyo’s (Japan) laboratory of bioanalytical chemistry, Graduate School of Pharmaceutical Science. “We discovered that the temperature difference is related to the various stages of the cell cycle.”

This research provides a unique point of view: Temperature not only regulates biologic molecules, but it in reality contributes to cellular functions. “By incorporating cellular temperature mapping into the analysis of any kind of cellular event, we can achieve a deeper understanding of cellular functions,” Dr. Okabe explained. “It is our hope that by using this method of temperature imaging, the pathogenesis of diseases known to generate significant heat within cells, such as cancer, can be clarified. We believe this may help lead to future cures.”

Dr. Okabe and coworkers now plan to research how temperature contributes to cellular functions in even greater detail, as well as examine discrepancies in the intracellular temperatures of a range of living cells.

Related Links:
University of Tokyo




Print article

Channels

Genomics/Proteomics

view channel
Image: A dark field photomicrograph showing the spirochete bacterium Borrelia burgdorferi, the pathogen responsible for causing Lyme disease (Photo courtesy of the CDC).

Statins May Help Block Transmission of Lyme Disease

A recent study found that treatment with cholesterol-lowering statins reduced the number of Borrelia burgdorferi bacteria in rodents, which helped to block transmission of Lyme disease. Lyme disease... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.